Safety, Tolerability, and Pharmacokinetics of Recombinant Human Neuregulin-1 in Healthy Chinese Subjects

被引：0
|
作者：
Junyu Xu
Peihong Sun
Xia Zhao
Lei Meng
Xiaorui Wang
Xiaoyan Qin
Ying Zhou
Mingdong Zhou
Yimin Cui
机构：
[1] Peking University First Hospital,Department of Pharmacy
[2] Peking University First Hospital,Department of Cardiology
[3] Zensun (Shanghai) Sci&Tech Co.,undefined
[4] Ltd.,undefined
来源：
American Journal of Cardiovascular Drugs | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：419 / 428
页数：9
相关论文
共 50 条
  • [21] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF BRIVARACETAM IN HEALTHY ELDERLY SUBJECTS
    Sargentini-Maier, Maria Laura
    Homery, Marie-Claude
    Stockis, Armel
    [J]. EPILEPSIA, 2008, 49 : 452 - 452
  • [22] Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Hyzetimibe (HS-25) in Healthy Chinese Subjects
    Ruan, Zhourong
    Jiang, Bo
    Chen, Jinliang
    Zhang, Xuehua
    Lou, Honggang
    Xiang, Meixiang
    Shao, Qingxiang
    Wang, Jian'an
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (10): : 1144 - 1152
  • [23] Safety, Tolerability, and Pharmacokinetics of Anaprazole, a Novel Proton Pump Inhibitor, in Healthy Chinese Subjects
    Wang, Fangfang
    Niu, Xiaoye
    Liu, Fei
    Ma, Xifeng
    Cheng, Fang
    Xu, Haiyan
    Wang, Li
    Xu, Yanjun
    Li, Haiyan
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (07): : 782 - 789
  • [24] Pharmacokinetics, Safety, and Tolerability of Glecaprevir and Pibrentasvir in Healthy White, Chinese, and Japanese Adult Subjects
    Lin, Chih-Wei
    Dutta, Sandeep
    Ding, Bifeng
    Wang, Tianli
    Zadeikis, Neddie
    Asatryan, Armen
    Kort, Jens
    Campbell, Andrew
    Podsadecki, Thomas
    Liu, Wei
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (12): : 1616 - 1624
  • [25] Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Biapenem in Healthy Adult Subjects
    Griffith, David C.
    Morgan, Elizabeth E.
    Dudley, Michael N.
    Loutit, Jeffery S.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (05)
  • [26] Comment on: Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Healthy Chinese Subjects
    Srinivas, Nuggehally R.
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (05) : 719 - 721
  • [27] Comment on: Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Healthy Chinese Subjects
    Nuggehally R. Srinivas
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2019, 44 : 719 - 721
  • [28] Safety, Tolerability and Pharmacokinetics of Single Ascending and Multiple Oral Doses of Tegoprazan in Healthy Chinese Subjects
    He, Jinjie
    Cao, Guoying
    Yu, Jicheng
    Wang, Jingjing
    Cheng, Nengneng
    Wu, Jufang
    Zhang, Jing
    Wu, Xiaojie
    Zhang, Basheng
    Lu, Jiayan
    Chen, Shangzhi
    [J]. CLINICAL DRUG INVESTIGATION, 2021, 41 (01) : 89 - 97
  • [29] Pharmacokinetics, Tolerability, Safety, and Immunogenicity of LY01008 and Bevacizumab (Avastin®) in Healthy Chinese Subjects
    Lijun Xie
    Ying Zhu
    Zuojun Liang
    Yuqing Zhao
    Sufeng Zhou
    Juan Chen
    Hongwen Zhang
    Sijia Ding
    Lu Wang
    Feng Shao
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2022, 47 : 309 - 317
  • [30] Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Sotagliflozin After Multiple Ascending Doses in Chinese Healthy Subjects
    He, Xuemei
    Gao, Xin
    Xie, Panpan
    Liu, Yuan
    Bai, Wenjing
    Liu, Yue
    Shi, Aixin
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 2967 - 2980
12345